Prediction of response to vemurafenib in BRAF V600E mutant cancers based on a network approach

被引：0
|
作者：
Falcone, R. [1 ]
Paci, P. [2 ]
Verrienti, A. [1 ]
Fiscon, G. [2 ]
Sponziello, M. [1 ]
Conte, F. [2 ]
Pecce, V. [1 ]
Rosignolo, F. [1 ]
Grani, G. [1 ]
Lamartina, L. [1 ]
Ramundo, V. [1 ]
Durante, C. [1 ]
Farina, L. [3 ]
Filetti, S. [1 ]
机构：
[1] Sapienza Univ Rome, Policlin Umberto 1, Dipartimento Med Interna & Specialita Med, Rome, Italy
[2] CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy
[3] Sapienza Univ Rome, Dept Stat Sci, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1887P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Del Bufalo, Francesca
    Ceglie, Giulia
    Cacchione, Antonella
    Alessi, Iside
    Colafati, Giovanna Stefania
    Carai, Andrea
    Diomedi-Camassei, Francesca
    De Billy, Emmanuel
    Agolini, Emanuele
    Mastronuzzi, Angela
    Locatelli, Franco
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [2] Vemurafenib in Melanoma with BRAF V600E Mutation
    Morita, Hiroyuki
    Nagai, Ryozo
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1448 - 1448
  • [3] Vemurafenib in Melanoma with BRAF V600E Mutation REPLY
    Chapman, Paul B.
    Hauschild, Axel
    McArthur, Grant A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1450 - 1450
  • [4] Hypoxia influences the response to vemurafenib in V600E mutant melanoma cells
    Pucciarelli, Daniela
    Takacova, Martina
    Csaderova, Lucia
    Juliano, Filippo
    Lengger, Nina
    Breiteneder, Heimo
    Pastorekova, Silvia
    Hafner, Christine
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
    Ali, Siraj M.
    He, Je
    Carson, Wade
    Stephens, Phil J.
    Fiorillo, Joseph
    Lipson, Doron
    Palmer, Gary A.
    Ross, Jeffrey S.
    Miller, Vincent A.
    Sharman, Jeffrey
    CASE REPORTS IN ONCOLOGY, 2014, 7 (02): : 343 - 348
  • [6] RECURRENT GANGLIOGLIOMA WITH BRAF V600E MUTATION RESPONSE TO VEMURAFENIB: CASE REPORT
    Aguilera, Dolly
    Mazewski, Claire
    Janss, Anna
    Castellino, Robert Craig
    Schniederjan, Matthew
    Hayes, Laura
    Brahma, Barun
    MacDonald, Tobey
    NEURO-ONCOLOGY, 2014, 16 : 61 - 61
  • [7] Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
    Chapman, Paul B.
    Hauschild, Axel
    Robert, Caroline
    Haanen, John B.
    Ascierto, Paolo
    Larkin, James
    Dummer, Reinhard
    Garbe, Claus
    Testori, Alessandro
    Maio, Michele
    Hogg, David
    Lorigan, Paul
    Lebbe, Celeste
    Jouary, Thomas
    Schadendorf, Dirk
    Ribas, Antoni
    O'Day, Steven J.
    Sosman, Jeffrey A.
    Kirkwood, John M.
    Eggermont, Alexander M. M.
    Dreno, Brigitte
    Nolop, Keith
    Li, Jiang
    Nelson, Betty
    Hou, Jeannie
    Lee, Richard J.
    Flaherty, Keith T.
    McArthur, Grant A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26): : 2507 - 2516
  • [8] A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib
    Gautschi, Oliver
    Pauli, Chantal
    Strobel, Klaus
    Hirschmann, Astrid
    Printzen, Gert
    Aebi, Stefan
    Diebold, Joachim
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (10) : E23 - E24
  • [9] BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report
    Peker, Yasar Subutay
    Can, Mehmet Fatih
    Ozerhan, Ismail Hakki
    Yagci, Gokhan
    Zeybek, Nazif
    Kavakli, Kutan
    Gurkok, Sedat
    Gozubuyuk, Alper
    Genc, Onur
    Erdem, Gokhan
    Ozet, Ahmet
    Gerek, Mustafa
    Peker, Yusuf
    CASE REPORTS IN SURGERY, 2018, 2018
  • [10] Vemurafenib selectively radiosensitizes BRAF V600E mutant papillary and anaplastic thyroid carcinoma cells
    Robb, Ryan N.
    Yang, Linlin
    Williams, Terence
    CANCER RESEARCH, 2017, 77
12345